CPTX-2506

N/A

Report date: 2025/09/09 15:05:50

Base Information

Drug NameCPTX-2506

Drug Alias NameCPTX-2506CPTX2506

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionT lymphocyte replacementsB-cell maturation protein modulators

TargetsB-cell maturation protein

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCapstan Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesCapstan Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsAutoimmune Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A